Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits
The proposed settlement aims to close a years-long legal battle over claims its talcs products cause cancer.
Johnson & Johnson (J&J) has put forward a settlement offer of up to $5.5 billion (£4.14 billion) to address tens of thousands of lawsuits that claim its baby powder and other talcum-containing products are responsible for causing ovarian cancer.
This significant proposed settlement seeks to conclude a protracted legal dispute that has burdened the healthcare corporation for several years. J&J has consistently denied any link between its talc-based products and cancer, and has since altered the formulation of its widely used baby powder.
Erik Haas, J&J's vice president of litigation, stated on Monday that the accusations are "meritless." He explained that the company is prepared to settle to bring the matter to a definitive close. Haas further commented in a statement that J&J is confident it would have "ultimately prevailed with further litigation," mirroring its success in the majority of cases heard in court thus far. He added that the proposed resolution "allows the company to put this matter behind it" and enables J&J to "remain focused on its mission to develop medicines and devices that save lives."
Legal actions against J&J concerning its talc-based baby powder began as early as 2009. In July, a federal court ruled in favor of the company by questioning the capacity of individual plaintiffs to demonstrate that talc was the direct cause of their ovarian cancer.
Talc, a natural mineral composed of magnesium, silicon, oxygen, and hydrogen, is recognized for its smooth texture and is frequently used in baby powder. The company has faced lawsuits from consumers and their surviving family members who allege that J&J's talc products led to cancer due to asbestos contamination. Talc is extracted from the earth and is found in geological formations near those containing asbestos, a substance known to cause cancer.
J&J has consistently refuted these allegations, stating in its most recent announcement: "Studies show talc is safe, does not contain asbestos and does not cause cancer."
In 2022, J&J announced its decision to cease the global manufacturing and sale of its talc-based baby powder. This announcement followed more than two years after the company had stopped selling the product in the United States. At the time, J&J stated: "As part of a worldwide portfolio assessment, we have made the commercial decision to transition to an all cornstarch-based baby powder portfolio."